Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 136
Selected: 0
NCT IDTitle
NCT02313298Stereotactic Body Radiotherapy for Organ Confined Prostate Cancer
NCT05957068Breast Cancer Exercise Intervention Study
NCT06956248Innovating Access to Novel Therapies Through Standardized Prospective Integration of Response Evaluations (IMPACT-INSPIRE)
NCT02801734Enhancing Quality of Life in Patients (EQUIP) Intervention for Patients With Advanced Lung Cancer
NCT04014309Accessible Cancer Care to Enable Support for Survivors Programme
NCT03430128Perioperative Immunonutrition for Patients Undergoing CRS and HIPEC
NCT03091491Study of Nivolumab Verses Nivolumab and Ipilimumab Combination in EGFR Mutant Non-small Cell Lung Cancer
NCT04620954Clinical Trial of Chemotherapy, Oregovomab and Nivolumab in Patients With Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin
NCT05517135tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrella)
NCT00003637Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously Untreated Cancer of the Nasopharynx
NCT01765686Comparing Harmonic Ultrasonic Scalpel to Small Jaw Bipolar Device in Thyroid Surgery
NCT06244953Timely Interventions to Enable and Reach Patients With Heart Failure, and Their Caregivers With Palliative Care
NCT04242251Novel Palliative Care Model for Advanced Cancer Patients: A Randomized Controlled Trial Study
NCT07111130Restoring Bile Acid Homeostasis Via Lifestyle Adjustments to Prevent the Development of Liver Cancer
NCT04961632Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376
NCT03188159Vinorelbine in Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer
NCT02944708Trial Evaluating Maintenance Chemotherapy for Metastatic Nasopharyngeal Carcinoma
NCT05581979PSMA-PET Imaging of Salivary Gland Tumours and Other Rare Cancers
NCT05198479Phase II 177Lu-DOTATATE Study in Metastatic NPC With a Safety Run-in
NCT00801411Cyclophosphamide and Docetaxel or Doxorubicin in Treating Women With Newly Diagnosed Breast Cancer That Can Be Removed by Surgery
NCT02850640Cost and Medical Care of Patients With Advanced Serious Illness in Singapore (COMPASS) Study
NCT05211882ENABLE (Educate, Nurture, Advise, Before Life Ends) Intervention for Heart Failure (HF) Patients and Their Caregivers in Singapore
NCT00702481Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancer
NCT03212937Phase I Trial of Selinexor (KPT-330) and Ifosfamide, Carboplatin, Etoposide (ICE) in Peripheral T-cell Lymphoma
NCT01570296A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFR
NCT01736410A Phase 2 Study of Trastuzumab in Combination With TS-ONE and Cisplatin in Firstline Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer
NCT04738708Telegenetics or In-Person Genetic Counselling
NCT00263484Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma
NCT03422432Prophylactic HIPEC for Colorectal Cancers at High Risk of Developing Peritoneal Metastases
NCT00870532Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung Cancer
NCT04632173Head and Neck cancERs International cOviD-19 collabOraTion
NCT02412267Study of Ofatumomab in Combination With ICE-chemotherapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL)
NCT00690872Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer
NCT04027647Phase 2 Study of Dacomitinib in NSCLC
NCT01341834Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors
NCT01135056Study to Compare Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (HCC)
NCT04664829The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBC
NCT04912765Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC
NCT04340024Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients
NCT06172595FET PET in Differentiating Tumour Progression From Pseudoprogression in High Grade Glioma
NCT06587295Intramuscular ACM-CpG Monotherapy in Patients With Advanced/Metastatic Solid Tumors With Prior Response to Immunotherapy Alone or in Combination With Chemotherapy
NCT07209501Evaluating the Feasibility and Acceptability of Inhalation Aromatherapy for Patients Undergoing Autologous Haematopoietic Stem Cell Transplant (HSCT)
NCT04230330Nivolumab in Combination With GDP/ L-asparaginase in NK/ T-cell Lymphoma
NCT00957086Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck Cancer
NCT03097939Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma
NCT04986748Using QPOP to Predict Treatment for Sarcomas and Melanomas
NCT06194084Impacts of Durian Consumption on Human Microbiome and Metabolome in Healthy Staff Volunteers
NCT06044441Evaluation and Implementation Preparation of a Proactive Palliative Care Model (ENABLE-SG)
NCT04965259Early Detection of Hepatocellular Carcinoma in a High-risk Prospective Cohort (ELEGANCE)
NCT00003576Surgery and Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer That Can Be Removed During Surgery